Showing results (31-40 of 120) with videos related to
Sort By:
Pageof 12
Urologia Internationalis|September 21, 2013
Fosfomycin trometamol (3,000 mg) in perioperative antibiotic prophylaxis of healthcare-associated infections after endourological interventions: a narrative reviewFlorian M E Wagenlehner, Petra M Thomas, Kurt G NaberChemotherapy|May 5, 2005
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infectionsFlorian M E Wagenlehner, Norbert Lehn, Wolfgang Witte, et al.Antimicrobial Agents and Chemotherapy|March 16, 2016
Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy SubjectsMarion Straubinger, Holger Blenk, Kurt G Naber, et al.Antibiotics (Basel, Switzerland)|December 23, 2020
Validation of the American English Acute Cystitis Symptom ScoreJakhongir F Alidjanov, Kurt G Naber, Adrian Pilatz, et al.Microbiology Spectrum|November 7, 2015
Urosepsis: Overview of the Diagnostic and Treatment ChallengesFlorian M E Wagenlehner, Adrian Pilatz, Wolfgang Weidner, et al.Medecine Et Maladies Infectieuses|January 24, 2012
French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapyYann Neuzillet, Kurt G Naber, Giancarlo Schito, et al.Expert Review of Pharmacoeconomics & Outcomes Research|July 25, 2017
Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)Florian Wagenlehner, Björn Wullt, Stefania Ballarini, et al.Current Opinion in Infectious Diseases|November 21, 2013
Urinary tract infections and bacterial prostatitis in menFlorian M E Wagenlehner, Wolfgang Weidner, Adrian Pilatz, et al.Expert Opinion on Emerging Drugs|June 24, 2010
Emerging drugs for bacterial urinary tract infectionsFlorian M E Wagenlehner, Wolfgang Weidner, Gianpaolo Perletti, et al.European Urology|May 31, 2008
Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapyKurt G Naber, Giancarlo Schito, Henry Botto, et al.Pageof 12